Evidence map›Paper›PMID 25418523›Full record

ArticleMolecular pharmaceutics2015

Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro.

Jamie L Betker, Thomas J Anchordoquy

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Exploiting a type III interferon response to improve chemotherapeutic safety and efficacy.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2025
    Article
  2. Review
  3. Reducing off-target drug accumulation by exploiting a type-III interferon response.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  4. Article
  5. The Use of Lactose as an Alternative Coating for Nanoparticles.Journal of pharmaceutical sciences · 2020
    Article
  6. Article
  7. Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jamie L BetkerSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado , Anschutz Medical Campus, 12850 East Montview Boulevard, Aurora, Colorado 80045, United States.
Thomas J Anchordoquy
University of Colorado Anschutz Medical Campus · USUniversity of Montana · US

Funding

Exploiting Cholesterol Nanodomains to Improve TargetingR01GM093287 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI ANCHORDOQUY, THOMAS · 2011 to 2014
$1.1M
NIGMS NIH HHS R01 GM093287NIGMS NIH HHS R01GM093287
6 · The paper itself

Abstract

Cationic reagents are commonly used to facilitate DNA delivery, and transfection experiments are typically initiated in cell culture where the optimal charge ratio is determined. While transfection rates are often enhanced at higher +/- charge ratios, the cellular toxicity associated with the greater amounts of cationic components at elevated charge ratios is often not considered. In addition, the prolonged effects of cationic lipid uptake on cell viability are not evident in a typical 24-48 h transfection experiment. In this study, we compare the transfection efficiency of cationic lipoplexes to effects on viability of cultured cells in both the short and long term (7 days). Our results indicate that, while minimal toxicity is evident 24 h after exposure to DOTAP-based lipoplexes, cell viability continues to decline and ultimately compromises reporter gene expression at longer times. Substitution of a naturally occurring cationic amphiphile, sphingosine, for DOTAP greatly reduces toxicity and allows high expression to be maintained over prolonged periods.

Indexed as

Gene Expression RegulationGene Transfer TechniquesCationsCell SurvivalDNAFatty Acids, MonounsaturatedFlow CytometryHumansLipidsLiposomesMCF-7 CellsParticle SizePhosphatidylcholinesPhosphatidylethanolaminesPlasmidsQuaternary Ammonium Compounds1,2-diarachidonoyl-glycero-3-phosphocholine1,2-dioleoyl-glycero-3-phosphatidyl ethanolamine1,2-dioleoyloxy-3-(trimethylammonium)propaneCationsDNAFatty Acids, MonounsaturatedLipidsLiposomesPhosphatidylcholinesPhosphatidylethanolaminesQuaternary Ammonium CompoundsSphingosinecationic lipidDOTAPsphingosinetoxicitytransfectionviability

Identifiers

PMID25418523
PMCPMC4291780
OpenAlexW2319168110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.